Product name:FG-2216
Description:A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Would like to ask specific details, please click here Email:sales@chemicalspharm.com
没有评论:
发表评论